Hosted on MSN25d
Is GSK plc (GSK) an Undervalued Defensive Stock for 2025?We then selected the top 12 stocks most popular among ... a therapy plan that includes pharmaceutical products. Formerly known as GlaxoSmithKline, GSK plc (NYSE:GSK) is a British global ...
GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...
India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin.
UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results